Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-12.96 Insider Own1.79% Shs Outstand2.96M Perf Week-8.94%
Market Cap2.50M Forward P/E- EPS next Y-3.01 Insider Trans0.00% Shs Float2.91M Perf Month-24.73%
Income-8.87M PEG- EPS next Q-0.50 Inst Own0.89% Short Float1.21% Perf Quarter-85.95%
Sales0.67M P/S3.72 EPS this Y62.43% Inst Trans- Short Ratio0.09 Perf Half Y-89.05%
Book/sh2.24 P/B0.38 EPS next Y44.97% ROA-90.94% Short Interest0.04M Perf Year-90.84%
Cash/sh1.23 P/C0.69 EPS next 5Y- ROE-220.34% 52W Range0.81 - 13.43 Perf YTD-89.51%
Dividend Est.- P/FCF- EPS past 5Y63.34% ROI-446.73% 52W High-93.72% Beta1.60
Dividend TTM- Quick Ratio3.24 Sales past 5Y33.74% Gross Margin-0.15% 52W Low3.93% ATR (14)0.12
Dividend Ex-Date- Current Ratio3.48 EPS Y/Y TTM80.83% Oper. Margin-1777.69% RSI (14)26.60 Volatility10.30% 10.16%
Employees22 Debt/Eq0.03 Sales Y/Y TTM-5.65% Profit Margin-1328.14% Recom1.00 Target Price4.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q30.36% Payout- Rel Volume0.19 Prev Close0.83
Sales Surprise22.73% EPS Surprise38.89% Sales Q/Q21.62% EarningsMay 13 AMC Avg Volume377.12K Price0.84
SMA20-14.40% SMA50-40.40% SMA200-84.44% Trades Volume69,899 Change0.96%
Date Action Analyst Rating Change Price Target Change
Mar-24-21Initiated Noble Capital Markets Outperform $20
Jun-28-24 06:00AM
Jun-17-24 07:00AM
Jun-06-24 07:38AM
May-31-24 12:30PM
09:00AM Loading…
May-29-24 09:00AM
May-23-24 09:00AM
May-20-24 09:00AM
May-13-24 08:53PM
May-10-24 09:00AM
May-08-24 07:31AM
May-07-24 07:39AM
May-06-24 10:15PM
08:12AM Loading…
May-03-24 08:12AM
Apr-24-24 09:05AM
Apr-03-24 07:05AM
Apr-01-24 12:18PM
Mar-28-24 04:05PM
Mar-15-24 07:05AM
Mar-12-24 08:59AM
Mar-07-24 07:00AM
Mar-04-24 07:00AM
Feb-06-24 07:00AM
Feb-05-24 07:05AM
Jan-11-24 07:00AM
Dec-07-23 09:55AM
Nov-30-23 07:47AM
11:07AM Loading…
Nov-13-23 11:07AM
Nov-09-23 04:05PM
Nov-06-23 07:05AM
Nov-02-23 05:05PM
Oct-20-23 02:34PM
Oct-12-23 07:05AM
Oct-02-23 07:05AM
Sep-28-23 07:00AM
Sep-21-23 07:05AM
Sep-20-23 07:05AM
Sep-13-23 07:05AM
Sep-06-23 09:55AM
Sep-05-23 07:00AM
Aug-16-23 09:00AM
Aug-13-23 08:13AM
Aug-11-23 07:33AM
Aug-10-23 06:15PM
Aug-07-23 07:05AM
Aug-02-23 04:05PM
Jul-27-23 07:05AM
Jun-20-23 07:05AM
Jun-14-23 04:05PM
May-25-23 07:05AM
May-24-23 07:05AM
May-19-23 05:00PM
May-16-23 12:14PM
May-12-23 06:31AM
May-11-23 04:05PM
May-04-23 04:05PM
Apr-17-23 07:05AM
Apr-16-23 06:30AM
Mar-24-23 12:29PM
Mar-23-23 05:00PM
Mar-22-23 07:05AM
Mar-10-23 06:22AM
Mar-09-23 04:05PM
Mar-06-23 07:30AM
Mar-02-23 04:05PM
Feb-15-23 07:05AM
Jan-23-23 07:05AM
Jan-19-23 09:00AM
Jan-10-23 07:05AM
Jan-05-23 07:41AM
Jan-03-23 07:05AM
Dec-30-22 04:05PM
Nov-17-22 12:00PM
Nov-14-22 06:30AM
Nov-09-22 07:05AM
Nov-08-22 07:05AM
Nov-03-22 07:05AM
Nov-01-22 07:05AM
Oct-13-22 07:05AM
Sep-29-22 05:20PM
Sep-14-22 05:05PM
Sep-06-22 06:30AM
Aug-18-22 12:00PM
Aug-15-22 04:05PM
Aug-10-22 07:05AM
Aug-05-22 08:38AM
Jul-15-22 10:55AM
Jul-12-22 07:05AM
Jun-17-22 12:00PM
Jun-06-22 07:05AM
Jun-01-22 07:05AM
May-31-22 08:36AM
May-24-22 04:05PM
May-17-22 07:30AM
May-12-22 06:50AM
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREEFF DANEPresident and CEODec 14 '23Buy8.105,00040,47516,512Dec 15 07:00 AM
ANDREEFF DANEPresident and CEODec 01 '23Buy6.452,00612,93513,685Dec 04 08:30 AM
ANDREEFF DANEPresident and CEONov 30 '23Buy6.372,00012,74112,551Dec 04 08:30 AM
ANDREEFF DANEPresident and CEOAug 30 '23Buy7.645,00038,21211,420Aug 30 08:42 PM
ANDREEFF DANEPresident and CEOAug 28 '23Buy6.375,07832,3398,774Aug 30 08:42 PM